BR112016026346A2 - Pyrrolidine-2,5-dione derivatives and their use, pharmaceutical compositions and medicine - Google Patents

Pyrrolidine-2,5-dione derivatives and their use, pharmaceutical compositions and medicine

Info

Publication number
BR112016026346A2
BR112016026346A2 BR112016026346A BR112016026346A BR112016026346A2 BR 112016026346 A2 BR112016026346 A2 BR 112016026346A2 BR 112016026346 A BR112016026346 A BR 112016026346A BR 112016026346 A BR112016026346 A BR 112016026346A BR 112016026346 A2 BR112016026346 A2 BR 112016026346A2
Authority
BR
Brazil
Prior art keywords
pyrrolidine
medicine
pharmaceutical compositions
dione derivatives
dione
Prior art date
Application number
BR112016026346A
Other languages
Portuguese (pt)
Other versions
BR112016026346A8 (en
Inventor
Crosignani Stefano
Cauwenberghs Sandra
Driessens Gregory
Deroose Frederik
Original Assignee
Iteos Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BE2014/0754A external-priority patent/BE1021251B1/en
Application filed by Iteos Therapeutics filed Critical Iteos Therapeutics
Priority claimed from PCT/IB2015/053557 external-priority patent/WO2015173764A1/en
Publication of BR112016026346A2 publication Critical patent/BR112016026346A2/en
Publication of BR112016026346A8 publication Critical patent/BR112016026346A8/en

Links

BR112016026346A 2014-05-15 2015-05-14 pyrrolidine-2,5-dione derivatives and their use, pharmaceutical compositions and medicine BR112016026346A8 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201461996976P 2014-05-15 2014-05-15
EP14168534 2014-05-15
BE2014/0754A BE1021251B1 (en) 2014-05-15 2014-10-21 PYRROLIDINE-2,5-DIONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE AS INHIBITORS OF IDO1
PCT/IB2015/053557 WO2015173764A1 (en) 2014-05-15 2015-05-14 Pyrrolidine-2,5-dione derivatives, pharmaceutical compositions and methods for use as ido1 inhibitors

Publications (2)

Publication Number Publication Date
BR112016026346A2 true BR112016026346A2 (en) 2017-08-15
BR112016026346A8 BR112016026346A8 (en) 2021-07-20

Family

ID=59858293

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016026346A BR112016026346A8 (en) 2014-05-15 2015-05-14 pyrrolidine-2,5-dione derivatives and their use, pharmaceutical compositions and medicine

Country Status (7)

Country Link
JP (1) JP2017214409A (en)
BR (1) BR112016026346A8 (en)
CL (1) CL2016002899A1 (en)
NI (1) NI201600171A (en)
PH (1) PH12016502281A1 (en)
SV (1) SV2016005317A (en)
ZA (1) ZA201607127B (en)

Also Published As

Publication number Publication date
ZA201607127B (en) 2018-05-30
PH12016502281A1 (en) 2017-02-13
JP2017214409A (en) 2017-12-07
NI201600171A (en) 2017-01-03
CL2016002899A1 (en) 2017-06-02
BR112016026346A8 (en) 2021-07-20
SV2016005317A (en) 2017-07-10

Similar Documents

Publication Publication Date Title
CL2018000813A1 (en) Antibody-pyrrolobenzodiazepine drug conjugates and methods of use.
IL248915A0 (en) Pyrrolidine-2,5-dione derivatives, pharmaceutical compositions and methods for use as ido1 inhibitors
BR112016030787A2 (en) chemical entity, pharmaceutical composition and its use
BR112016016158A2 (en) BICYCLIC HETEROCYL DERIVATIVES AS IRAK4 INHIBITORS, THEIR PHARMACEUTICAL COMPOSITION AND THEIR USES
DK3125883T3 (en) CONTENTS DERIVATIVES FOR USE IN MEDICINE
CL2016002569A1 (en) Antibodies, pharmaceutical compositions and uses thereof
BR112016022062A2 (en) Combination, pharmaceutical composition, use of a combination or pharmaceutical composition, and pharmaceutical product
IL247062A0 (en) Heterocyclic compounds , their preparation and compositions pharmaceutical containing them
BR112016015838A2 (en) heterocyclic aromatic compounds, pharmaceutical composition comprising said compounds and combination product
BR112016020199A2 (en) Human plasma kallikrein inhibitor compound, pharmaceutical composition comprising said compound, kit and its use
BR112016023628A2 (en) pharmaceutical compositions.
BR112016018062A2 (en) therapeutic compounds, pharmaceutical composition and uses
MA50541A (en) PHARMACEUTICAL FORMULATIONS
MA42303A (en) PHARMACEUTICAL FORMULATIONS
MA46867A (en) PHARMACEUTICAL FORMULATIONS
DK3634377T3 (en) Pharmaceutical formulation
HK1256674A1 (en) Deuterium-modified brigatinib derivatives, pharmaceutical compositions comprising same, and use thereof
DK3554534T3 (en) PHARMACEUTICAL COMPOSITION INCLUDING INSULIN
BR112017013012A2 (en) indenyl compounds, pharmaceutical compositions and medical uses thereof
BR112016026552A2 (en) carboxamide derivatives, their uses, pharmaceutical composition, and combination
DK3275452T3 (en) PHARMACEUTICAL COMPOSITION WITH SILIBININE
MA45187A (en) PHARMACEUTICAL COMBINATIONS
MA49837A (en) PHARMACEUTICAL COMPOSITIONS
BR112016019868A2 (en) tatk-cdkl5 fusion proteins, compositions, formulations, and their use
IL248773B (en) 1,6-naphthyridine-4,5-dione derivatives and pharmaceutical compositions comprising them

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements